ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 70 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,929,451 | +14.8% | 2,351,917 | +3.1% | 0.00% | 0.0% |
| Q2 2023 | $23,455,795 | +95.7% | 2,281,692 | +46.9% | 0.00% | – |
| Q1 2023 | $11,988,543 | +13.5% | 1,552,920 | +8.1% | 0.00% | – |
| Q4 2022 | $10,560,920 | +58.1% | 1,436,860 | +54.9% | 0.00% | – |
| Q3 2022 | $6,679,000 | -10.7% | 927,723 | +5.6% | 0.00% | – |
| Q2 2022 | $7,476,000 | +15.2% | 878,368 | +21.5% | 0.00% | – |
| Q1 2022 | $6,487,000 | -35.7% | 723,138 | -0.8% | 0.00% | – |
| Q4 2021 | $10,095,000 | +72.7% | 728,848 | +33.1% | 0.00% | – |
| Q3 2021 | $5,844,000 | +19.3% | 547,782 | +0.7% | 0.00% | – |
| Q2 2021 | $4,898,000 | +1624.6% | 544,155 | +1933.8% | 0.00% | – |
| Q1 2021 | $284,000 | -12.6% | 26,756 | +3.9% | 0.00% | – |
| Q4 2020 | $325,000 | +20.4% | 25,755 | -16.2% | 0.00% | – |
| Q3 2020 | $270,000 | -7.2% | 30,745 | +2.8% | 0.00% | – |
| Q2 2020 | $291,000 | +327.9% | 29,904 | +27.0% | 0.00% | – |
| Q1 2020 | $68,000 | -26.1% | 23,541 | -2.2% | 0.00% | – |
| Q4 2019 | $92,000 | -4.2% | 24,081 | -0.5% | 0.00% | – |
| Q3 2019 | $96,000 | -8.6% | 24,201 | -2.7% | 0.00% | – |
| Q2 2019 | $105,000 | -38.6% | 24,861 | -0.3% | 0.00% | – |
| Q1 2019 | $171,000 | +81.9% | 24,946 | -3.3% | 0.00% | – |
| Q4 2018 | $94,000 | -43.0% | 25,800 | -0.9% | 0.00% | – |
| Q3 2018 | $165,000 | -14.1% | 26,044 | +2.2% | 0.00% | – |
| Q2 2018 | $192,000 | +8.5% | 25,495 | +16.1% | 0.00% | – |
| Q1 2018 | $177,000 | -28.3% | 21,963 | -0.7% | 0.00% | – |
| Q4 2017 | $247,000 | 0.0% | 22,116 | +3.5% | 0.00% | – |
| Q3 2017 | $247,000 | – | 21,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $76,809,898 | 25.63% |
| Lynx1 Capital Management LP | 2,404,614 | $27,532,830 | 18.21% |
| GREAT POINT PARTNERS LLC | 3,078,633 | $35,250,348 | 6.42% |
| Ghost Tree Capital, LLC | 664,132 | $7,604,311 | 2.50% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $34,186,918 | 2.27% |
| Paradigm Biocapital Advisors LP | 2,421,743 | $27,728,957 | 1.88% |
| COMMODORE CAPITAL LP | 1,325,000 | $15,171,250 | 1.77% |
| Nan Fung Group Holdings Ltd | 182,280 | $2,087,106 | 1.69% |
| Omega Fund Management, LLC | 153,700 | $1,759,865 | 1.62% |
| Octagon Capital Advisors LP | 750,000 | $8,587,500 | 1.32% |